Alexion Pharmaceuticals, Inc. (ALXN)
(Delayed Data from NSDQ)
$136.69 USD
+3.56 (2.67%)
Updated May 3, 2019 04:00 PM ET
After-Market: $136.70 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
ALXN 136.69 +3.56(2.67%)
Will ALXN be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for ALXN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ALXN
Alexion Pharmaceuticals (ALXN) Earnings Expected to Grow: Should You Buy?
ALXN vs. TECH: Which Stock Is the Better Value Option?
ALXN: What are Zacks experts saying now?
Zacks Private Portfolio Services
AbbVie (ABBV) Venclexta Gets Breakthrough Therapy Tag for MDS
Bayer's (BAYRY) Parkinson's Disease Therapy Gets Fast Track Tag
Moderna Soars on Inclusion to S&P 500: ETFs in Focus
Other News for ALXN
No Record found.